Potential use of terbinafine in the treatment of chromoblastomycosis

Reviews in Contemporary Pharmacotherapy

Volumn 8, Issue 5, 1997, Pages 357-361

  Esterre, P ^a   Ratsioharana, M ^a   Roig, P ^b  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b NOVARTIS PHARMA K K   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME; TERBINAFINE;

ARTICLE; CHROMOMYCOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHYTE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MADAGASCAR; NEUTROPHIL; ORAL DRUG ADMINISTRATION;

EID: 0030678142     PISSN: 09548602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Andriantsimahavandy A, Michel P, Rasolofonirina H, Roux J. Apport de l'Immunologie au diagnostic de la chromomycose à Madagascar. J Mycol Med 1993; 3: 30-36.
2. Balfour JA, Faulds D. Terbinafine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in superficial mycosis. Drugs 1992; 43: 259-284.
3. Bayles MAH. Chromomycosis: treatment with thiabendazole. Arch Dermatol 1971; 104: 476-485.
4. Bolzinger T, Pradinaud R, Dainte-Marie D, Dupont B, Chwetzoff E. Treatment of four cases of chromomycosis with Fonsecaea pedrosoi by combination of 5-fluorocytosine and itraconazole. Nouv Dermatol 1991; 10: 462-466.
5. Campbell IT, Reis C, Faria E, Campbell GAM. Chromomycosis: treatment by thermotherapy. Nouv Dermatol 1991; 10: 468-470.
6. Esterre P, Peyrol S, Sainte-Marie D, Pradinaud R, Grimaud JA. Granulomatous reaction and tissue remodelling in the cutaneous lesion of Chromomycosis. Virchows Arch 1993; 422: 285-291.
7. Esterre P, Inzan CK, Ramarcel ER et al. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol 1996a; 134 (Suppl 46): 33-36.
8. Esterre P, Andriantsimahavandy A, Ramarcel ER, Pecarrere JL. Forty years of chromoblastomycosis in Madagascar: a review. Am J Trop Med Hyg 1996b; 55: 45-47.
9. Esterre P, Inzan C, Ratsioharana M et al. Evaluation of terbinafine (Lamisil®) in the treatment of chromoblastomycosis. J Eur Acad Dermatol Venereol 1996c; 7: S95.
10. Faergemann J, Zehender H, Jones T, Malbach I. Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat. Acta Derm Venereol 1991; 71: 322-326.
11. Finlay AY. Global overview of Lamisil®. Br J Dermatol 1994; 130: 1-3.
12. Fuchs J, Milbradt R, Pecher SA. Diagnostic features of chromoblastomycosis and lobomycosis. Eur J Dermatol 1993; 3: 202-205.
13. Galperin C, Shoenfeld Y, Esterre P, Meroni PL, Halpern G, Gershwin ME. Antineutrophilic cytoplasmic antibodies in patients with chromomycosis. Eur J Rheum 1996; 14: 479-483.
14. Heyl T. Treatment of chromomycosis with itraconazole. Br J Dermatol 1985; 112: 728-729.
15. Iijima S, Takase T, Otsuka F. Treatment of chromomycosis with oral high-dose of amphotericin B. Arch Dermatol 1995; 131: 399-401.
16. Lubritz R, Spence J. Chromoblastomycosis: cure by cryosurgery. Int J Dermatol 1978; 17: 830-832.
17. Nolting S, Brautigam M, Weidinger G. Terbinafine in onychomycosis with involvement by non-dermatophytic fungi. Br J Dermatol 1994; 130: 16-21.
18. Olle-Goig JE, Domingo J. A case of chromomycosis treated with thiabendazole. Trans R Soc Trop Med Hyg 1983; 77: 773-774.
19. Picardo M, Pigatto P, Cristaudo A, Colombo D, Cannistraci C, Bigardi AS. Anti-inflammatory activity of terbinafine in vivo. J. Eur Acad Dermatol Venereol 1996; 7: S120.
20. Randhawa HS, Budimulja U, Bazaz-Malik G et al. Recent developments in the diagnosis and treatment of subcutaneous mycoses. J Med Vet Mycol 1994; 32: 299-307.
21. Restrepo A, Gonealez A, Gomez I, Arango M, Debedout C. Treatment of chromomycosis with itraconazole. Ann N Y Acad Sci 1988; 544: 504-516.
22. Ryder NS. Terbinafine: mode of action and properties of squalene inhibition. Br J Dermatol 1992; 126: 2-7.
23. Salfelder K. Chromoblastomycosis. In: Salfelder K, De Liscano TR, Saverteig E, eds. Current histopathology: atlas of fungal pathology. Dordrecht, Netherlands: Kluwer Ac. Press, 1990; 145-150.
24. Sandoz. Lamisil®, a novel antifungal agent: clinical and technical review. Basel: Sandoz Pharma Ltd, 1992.
25. Tagami H, Ginoza M, Imaizumi S. Successful treatment of chromoblastomycosis with topical heat therapy. J Am Acad Dermatol 1984; 10: 615-618.
26. Tuffanelli L, Milburn PB. Treatment of chromoblastomycosis. J Am Acad Dermatol 1990; 23: 728-732.